Directory

>

Douglas Girgenti

avatar

Douglas Girgenti

Genetics and Oncogene Research | Melinta Therapeutics

New York, Town of Yorktown, United States

View contact details (it's free)

Douglas Girgenti

Summary

Douglas Girgenti is a seasoned medical professional with extensive experience in drug development and clinical research. As the Vice President of Drug Development at Melinta Therapeutics, he leads innovative projects in the pharmaceutical industry, focusing on vaccines and rare diseases. With a background in both pediatrics and adult medicine, Douglas has a unique perspective on patient care and clinical efficacy. His previous roles at renowned companies such as Pfizer and Boehringer Ingelheim highlight his expertise in immunology and clinical program leadership. A graduate of Stony Brook University with an M.D., he also holds dual bachelor's degrees in Genetics and Microbiology from Cornell University. Fluent in Spanish, he is well-equipped to engage with diverse populations in healthcare settings. Douglas is passionate about advancing medical research and improving patient outcomes through innovative therapies.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Douglas Girgenti

Work Experience

company logo

Vice President of Drug Development at

Melinta Therapeutics

October 2021 - Present

Logos provided by Logo.dev

Douglas Girgenti

Education

Cornell University, Bachelor's Degree, Genetics, Microbiology

January 1986 - January 1989

Stony Brook University, Doctor of Medicine (M.D.)

January 1990 - January 1994

Cornell University, Bachelor of Science - BS, Microbiology/Genetics

January 1986 - January 1989

Frequently Asked Questions about Douglas Girgenti

What is Douglas Girgenti email address?

Douglas Girgenti's primary email address is ****************@boehringer-ingelheim.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Douglas Girgenti work for?

Douglas Girgenti is a Genetics and Oncogene Research at Melinta Therapeutics.

Where Douglas Girgenti graduated from?

Douglas Girgenti holds a degree in null from Cornell University.

How can I directly contact Douglas Girgenti?

To contact Douglas Girgenti directly, you can use the email address ****************@boehringer-ingelheim.com. Complete contact information is available upon registration with Muraena.

Who is Douglas Girgenti?

Douglas Girgenti is a seasoned medical professional with extensive experience in drug development and clinical research. As the Vice President of Drug Development at Melinta Therapeutics, he leads innovative projects in the pharmaceutical industry, focusing on vaccines and rare diseases. With a background in both pediatrics and adult medicine, Douglas has a unique perspective on patient care and clinical efficacy. His previous roles at renowned companies such as Pfizer and Boehringer Ingelheim highlight his expertise in immunology and clinical program leadership. A graduate of Stony Brook University with an M.D., he also holds dual bachelor's degrees in Genetics and Microbiology from Cornell University. Fluent in Spanish, he is well-equipped to engage with diverse populations in healthcare settings. Douglas is passionate about advancing medical research and improving patient outcomes through innovative therapies.

Douglas`s contact details

mail

****************@boehringer-ingelheim.com

*********@melinta.com

Colleagues

Mark Redell

VP Medical Affairs

avatar
Dave Baran

Sr. Clinical Research Associate (Clinical Pharmacology)

avatar
Christine Ann Miller

Chemical Engineer

avatar
David Newman

Product Manager, Kytril

avatar
Greg Gangemi

Sales Representative

avatar
Alisha Haines

Oncology Sales Training Manager / Sales Manager / Region Trainer / Sales Representative

avatar
Kristen Allgor

Benefits Manager

View Contact details (it's free)
Request Profile Removal